Evaluating the informativity and specificity of diagnostic criteria for primary screening for acromegaly
Background. The most effective method for early diagnosis of any disease, and especially such rare as acromegaly, is considered to be population screening in highrisk groups, the introduction of which in Ukraine requires the development of methodological approaches and economic substantiation. The purpose of the study: based on a comparative analysis, to determine the informativity and specificity of questions that will be included in the questionnaire of primary screening for acromegaly. Materials and methods. The survey was conducted in two groups of people: group 1 — patients with diagnosis of acromegaly verified in the neuroendocrinology center of State Institution “V. Danilevsky Institute for Endocrine Pathology Problems of the National Academy of Medical Sciences of Ukraine” (n = 123); group 2 (n = 550) — persons from the risk group, namely, those who came to an outpatient visit to a general practitioner, therapist, cardiologist, endocrinologist for various reasons and in the presence of somatic and/or endocrine pathology. The evaluation of the obtained data was carried out by the analysis of variance using the software complex SPSS 19.0 (IBM Corp., Armonk, NY, USA). Results. The first set of questions in the developed questionnaire is the evaluation of phenotypic characteristics, that is, the patient’s assessment of changes in his/her appearance. The second set of questions is the determination of complaints by patients that can be a sign of the presence of a pathological process in the central nervous system and pituitary gland. Based on the comparative analysis, in the final version, the questionnaire had 11 questions, which reflect the most significant signs and clinical manifestations of permanent excessive growth hormone. The questionnaire is intended for interviewing individuals at risk in order to carry out opportunistic screening for acromegaly. Conclusions. The proposed method for evaluating the significance of clinical signs of acromegaly allows us to determine with a high degree of probability the final questions for the screening questionnaire.
Full Text:PDF (Українська)
Bernabeu I, Aller J, Álvarez-Escolá C, et al. Criteria for diagnosis and postoperative control of acromegaly, and screening and management of its comorbidities: Expert consensus. Endocrinol Diabetes Nutr. 2018;65(5):297-305. doi: 10.1016/j.endinu.2018.01.008.
Petrossians P, Tichomirowa MA, Stevenaert A, et al. The Liege Acromegaly Survey (LAS): a new software tool for the study of acromegaly. Ann Endocrinol (Paris). 2012;73(3):190-201. doi: 10.1016/j.ando.2012.05.001.
Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury. Clin Endocrinol (Oxf). 2010 Mar;72(3):377-82. doi: 10.1111/j.1365-2265.2009.03667.x.
Molitvoslovova N, Przhiyalkovskaya E, Rozhinskaya L, Melnichenko G. Russian register of patients with hypothalamo-hypophyseal disorders: update to May 2010. In: Abstract book of 14th Congress of ENEA. Liege. 2010;58:119.
Khyzhnyak O, Nikolaiev R, Guk M, Nikolaiev R, Gogitidze T. Clinical and hormonal features of acromegaly in patients from a Ukrainian neuroendocrinology centre. Problemi endokrinnoi patologii. 2019;68(2):110-130. doi: org/10.21856/j-PEP.2019.2.17.
Mykytiuk MR, Khyzhnyak OO. Analysis of national registries of patients with acromegaly of foreign countries and own observations. Endokrynologiya. 2010;15(1):107-114. (in Ukrainian).
Daly AF, Cogne M, Jaffrain-Rea MX, et al. The epidemiology of pituitary tumors: results of an international collaborative study. In: The Endocrine Society Annual Meeting, Toronto Canada, June 2-5, 2007.
Khyzhnyak O, Velykykh N, Levchenko T, et al. Clinical observation of combined pathology – acromegaly and fibrous osteodysplasia (McCune-Albright syndrome). Problemi Endokrynnoi Patologii. 2008;4:56-62. (in Russian).
Cochrane AL, Holland WW. Validation of screening procedures. British Medical Bulletin. 1971;27(1):3-8.
Lesén E, Granfeldt D, Houchard A, et al. Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study. Eur J Endocrinol. 2017;176(2):203-212. doi: 10.1530/EJE-16-0623.
This work is licensed under a Creative Commons Attribution 4.0 International License.
© "Publishing House "Zaslavsky", 1997-2020